Mydriasis Treatment Market is driven by Increasing Ophthalmology Procedures
The mydriasis treatment market has witnessed significant growth due to the increasing number of ophthalmology procedures globally. Mydriasis is a condition associated with pupil dilation that can occur due to pupil dilation drugs, ocular inflammation, or trauma. The signs and symptoms include blurred vision, eye pain, and sensitivity to light. Mydriasis can be treated through cholinergic drugs that cause pupil constriction. Some commonly used drugs include pilocarpine and physostigmine.
The mydriasis treatment market is estimated to be valued at USD 633.3 Mn in 2024 and is expected to reach USD 878 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.
The increasing prevalence of ocular diseases and growing geriatric population are fueling the demand for Mydriasis Treatment Market. According to the World Health Organization (WHO) estimates, at least 2.2 billion people have a vision impairment or blindness, of which at least 1 billion cases are preventable or have yet to be addressed.
Get more insights on: Mydriasis Treatment Market
Get this Report in Japanese Language: 散瞳治療市場
Get this Report in Korean Language: 산동증 치료 시장
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian